Renaissance Technologies’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$82K Sell
27,625
-14,556
-35% -$43.2K ﹤0.01% 3331
2025
Q1
$96.2K Sell
42,181
-794
-2% -$1.81K ﹤0.01% 3202
2024
Q4
$161K Buy
42,975
+26,828
+166% +$100K ﹤0.01% 3218
2024
Q3
$48.4K Buy
+16,147
New +$48.4K ﹤0.01% 3349
2023
Q3
Sell
-11,267
Closed -$35K 4195
2023
Q2
$35K Sell
11,267
-3,861
-26% -$12K ﹤0.01% 3678
2023
Q1
$42K Buy
+15,128
New +$42K ﹤0.01% 3699
2022
Q1
Sell
-11,630
Closed -$88K 4546
2021
Q4
$88K Buy
11,630
+4,395
+61% +$33.3K ﹤0.01% 3706
2021
Q3
$87K Sell
7,235
-29,103
-80% -$350K ﹤0.01% 3336
2021
Q2
$979K Buy
+36,338
New +$979K ﹤0.01% 2679
2021
Q1
Sell
-40,083
Closed -$625K 3786
2020
Q4
$625K Buy
+40,083
New +$625K ﹤0.01% 2724
2020
Q3
Sell
-20,054
Closed -$452K 3760
2020
Q2
$452K Buy
20,054
+17,361
+645% +$391K ﹤0.01% 2912
2020
Q1
$49K Sell
2,693
-7,113
-73% -$129K ﹤0.01% 3324
2019
Q4
$1.15M Buy
9,806
+4,575
+87% +$538K ﹤0.01% 2561
2019
Q3
$475K Buy
+5,231
New +$475K ﹤0.01% 2885
2019
Q2
Sell
-510
Closed -$25K 3792
2019
Q1
$25K Buy
+510
New +$25K ﹤0.01% 3390
2018
Q4
Sell
-1,275
Closed -$79K 3667
2018
Q3
$79K Buy
1,275
+887
+229% +$55K ﹤0.01% 3255
2018
Q2
$11K Buy
+388
New +$11K ﹤0.01% 3223
2018
Q1
Sell
-6,031
Closed -$273K 3623
2017
Q4
$273K Buy
6,031
+5,585
+1,252% +$253K ﹤0.01% 3045
2017
Q3
$30K Sell
446
-119
-21% -$8K ﹤0.01% 3147
2017
Q2
$36K Sell
565
-302
-35% -$19.2K ﹤0.01% 3139
2017
Q1
$57K Sell
867
-71
-8% -$4.67K ﹤0.01% 3131
2016
Q4
$56K Buy
938
+200
+27% +$11.9K ﹤0.01% 3159
2016
Q3
$63K Buy
738
+94
+15% +$8.02K ﹤0.01% 3230
2016
Q2
$43K Buy
644
+11
+2% +$734 ﹤0.01% 3245
2016
Q1
$46K Buy
633
+198
+46% +$14.4K ﹤0.01% 3287
2015
Q4
$53K Buy
435
+301
+225% +$36.7K ﹤0.01% 3170
2015
Q3
$17K Buy
134
+66
+97% +$8.37K ﹤0.01% 3113
2015
Q2
$10K Buy
+68
New +$10K ﹤0.01% 3194